Estudio ROSA: validación de la versión española de la Relevant Outcome Scale for Alzheimer's Disease

Carnero-Pardo, C.; Alcalde, S. López; Garcia, Milena; Magro, Isabel Sánchez

doi:10.1016/j.nrl.2015.12.007

Cited by 2 publications

(2 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results of internal consistency reliability and test-retest reliability of the CROSA were satisfactory. The Cronbach's alpha for the scale among the entire sample (0.900) was similar to those of the original (Holthoff et al, 2011) and Spanish versions (Pardo et al, 2017), and the Cronbach's alpha was also satisfactory for the scale among each stage. The Cronbach's alphas were good or acceptable for each domain among the entire sample and each stage.…”

Section: Discussionmentioning

confidence: 58%

“…Caregiver burden and PWAD QoL are important outcomes in studies on the dyads (Jia et al, 2020;Livingston et al, 2017). In addition, compared to the other multi-domain instruments, only the ROSA has been validated in multiple countries (including Germany, Austria and Spain) and published in multilingual versions (Holthoff et al, 2011;Pardo et al, 2017).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Validation of the Chinese Version of the Relevant Outcome Scale for Alzheimer’s Disease (CROSA)

Zhang

Yang

et al. 2021

Int. Psychogeriatr.

View full text Add to dashboard Cite

Objectives: To examine the psychometric properties of the Chinese version of the Relevant Outcome Scale for Alzheimer’s disease (CROSA) among persons with AD (PWAD) and their caregivers in China. Design: A single-arm, open-label, multi-center study. Setting: Two tertiary general hospitals in Shanghai. Participants: A total of 336 PWAD and their family caregivers. Intervention: The PWAD completed a 12-week treatment with memantine after a baseline assessment. Measurements: The CROSA and the Chinese versions of the Mini-Mental State Examination, the Alzheimer’s Disease Assessment Scale-Cognitive Subscale, the Disability Activity of Dementia, the Neuropsychiatric Inventory Questionnaire, the Zarit Caregiver Burden Interview and the Self-Efficacy Questionnaire for Chinese Family Caregivers. Results: The Cronbach’s alpha for the total scale was 0.900, and the intraclass correlation coefficient and Pearson’s correlation coefficient were 0.910 (P < 0.001) and 0.836 (P < 0.001), respectively. Confirmatory factor analysis revealed the two-factor model to be consistent with the original version. For the known-group validity, the total score of the CROSA classified the PWAD into three stages and three MMSE score groups. Moderate to large correlations with the validated scales confirmed the criteria validity of the CROSA, and the convergent validity was confirmed via testing a hypothesized caregiving model; however, only minimal responsiveness was found among the deterioration group after 12 weeks of treatment with memantine. Conclusions: The reliability and validity of the CROSA was good or acceptable for use in daily clinical settings. Further studies are needed to examine the psychometric properties of the scale.

show abstract

Section: Discussionmentioning

confidence: 58%